Trupanion (0LH0.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
You don't hold 0LH0.L in your mock portfolio yet.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Trupanion remains unprofitable, as reflected in its negative EPS of -0.79 and a negative PE ratio of -29.12, indicating the market is valuing the company on growth expectations rather than current earnings. The lack of positive earnings and profitability pressure suggests ongoing execution and margin challenges, even if revenue is likely still growing. Until there is a clearer path to sustained profitability, the financial profile skews risk‑heavy.
At $23.03, Trupanion is trading below its 200‑day moving average of $26.72, which is generally a sign of a longer‑term downtrend or at least technical overhead resistance. The recent 3.3% gain over the last month and an RSI of 52.76 suggest the stock is in a neutral momentum zone—neither overbought nor oversold—with modest short‑term strength but no clear breakout signal. Overall, price action points to consolidation rather than a decisive bullish or bearish technical setup.
Alternative data for Trupanion show constructive signs: web traffic is sizable at over 1 million monthly visitors, and job openings have increased 19.4% month over month, suggesting ongoing investment in growth and operations. Social media followings are broadly stable to slightly rising across most platforms, indicating steady brand engagement rather than deterioration. Collectively, these signals point to a business that is still actively expanding and maintaining customer interest.
Trupanion’s stock setup is mixed: operational and demand‑side alternative data look constructive, but the company remains unprofitable and the share price trades below its long‑term moving average. The balance of negative earnings with improving alternative data and neutral technicals leads to an overall neutral stance, with upside dependent on clear progress toward profitability. Investors may see potential if growth translates into better margins, but current fundamentals still warrant caution.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started